Alterations of E-cadherin and β-catenin in gastric cancer

BMC Cancer

Volumn 1, Issue , 2001, Pages

  Huiping, Chen ^a   Kristjansdottir, Sigrun ^a   Jonasson, Jon G ^a   Magnusson, Jonas ^a   Egilsson, Valgardur ^a   Ingvarsson, Sigurdur ^b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MESSENGER RNA; UVOMORULIN;

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CARCINOMA CELL; CELL ADHESION; COLON CARCINOMA; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC TRANSCRIPTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; OVARY CARCINOMA; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECTUM CARCINOMA; RNA ANALYSIS; SARCOMA; STOMACH CANCER; THYROID CARCINOMA; TUMOR CLASSIFICATION;

EID: 3042652925     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-1-16     Document Type: Article

References (35)

1. Shiozaki H, Oka H, Inoue M, Tamura S, Monden M: E-cadherin mediated adhesion system in cancer cells. Cancer 1996, 77:1605-1613
2. De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S: Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997, 183:404-411
3. Yasui W, Kuniyasu H, Akama Y, Kitahara K, Nagafuchi A, Ishihara S, Tsukita S, Tahara E: Expression of e-cadherin, alpha-catenins and beta-catenins in human gastric carcinomas - correlation with histology and tumor progression. Oncol Rep 1995, 2:111-117
4. Huiping C, Sigurgeirsdottir JR, Jonasson JG, Eiriksdottir G, Johannsdottir JT, Egilsson V V, Ingvarsson S: Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Br J Cancer 1999, 81:1103-1110
5. St Croix B, Sheehan C, Rak JW, Florenes VA, Slingerland JM, Kerbel RS: E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27 (KIP1). J Cell Biol 1998, 142:557-571
6. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991, 66:107-119
7. Jankowski JA, Bruton R, Shepherd N, Sanders DS: Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Mol Pathol 1997, 50:289-290
8. Wijnhoven BPL, Dinjens WNM, Pignatelli M: E-cadherin-catenin cell-cell adhesion complex and human cancer. Bri J Surg 2000, 87:992-1005
9. Birchmeier W, Hulsken J, Behrens J: Adherens junction proteins in tumour progression. Cancer Surv 1995, 24:129-140
10. Tsuda H, Zhang WD, Shimosato Y, Yokota J, Terada M, Sugimura T: Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci 1990, 87:6791-6794
11. Wijnhoven BP, de Both NJ, van Dekken H, Tilanus HW, Dinjens WN: E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus. Br J Cancer 1999, 80:1652-1657
12. Kimura T, Sato H, Manabe R, Konishi H, Kushima R, Sugihara H, Hattori T, Kodama T, Kashima K: Analysis of microsatellite regions and DNA ploidy pattern in signet ring cell carcinomas of the stomach. Japanese Journal of Cancer & Chemotherapy 1997, 24:273-278
13. Berx G, Becker KF, Hofler H, van Roy F: Mutations of the human E-cadherin (CDH1) gene. Hum Mutat 1998, 12:226-237
14. Berx G, Cleton-Jansen AM, de Strumane K, Leeuw WJ, Nollet F, van Roy F: E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996, 13:1919-1925
15. Machado JC, Soares P, Carneiro F, Rocha A, Beck S, Blin N: E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest 1999, 79:459-465
16. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P: E-cadherin germline mutations in familial gastric cancer. Nature 1998, 392:402-405
17. Richards FM, McKee SA, Rajpar MH, Cole TR, Evans DG, Jankowski JA: Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 1999, 8:607-610
18. Samowitz WS, Powers MD, Spirio LN, Nollet F, Roy FV, Slattery ML: β-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res 1999, 59:1442-1444
19. Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS, Kim SY, Lee HK, Kim PJ, Oh ST, Yoo NJ, Lee JY: Frequent somatic mutations of the β-catenin gene in intestinal-type gastric cancer. Cancer Res 1999, 59:4257-4260
20. Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanagihara K: A truncated beta-catenin disrupts the interaction between Ecadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 1994, 54:6282-6287
21. Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N, Niitsu Y: Loss of E-cadherin-dependent cell - cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 1995, 15:1175-1181
22. Smith SA, Easton DF, Evans DGR, Ponder BAJ: Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 1992, 2:128-131
23. Vignal A, Gyapay G, Hazan J, Nguyen S, Dupraz C, Cheron N: Nonradioactive multiplex procedure for genotyping of microsatellite markers. Methods in Molecular Genetics 1993 Vol. 1. San Diego: Academic Press Inc, 211-221
24. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994, 54:3845-3852
25. Hazelbag HM, Van de Brock LJCM, Van Dorst EBL, Offerhaus GJA, Fleuren GJ, Hogendoorn PCM: Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissue: a comparison of various antigen retrieval systems using microwave heating and proteolytic pretreatments. J Histochem Cytochem 1995, 43:4429-437
26. Mansouri A, Spurr N, Goodfellow PN, Kemler R: Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. Differentiation 1988, 38:67-71
27. Shimoyama Y, Hirohashi S: Expression of E- and P-cadherin in gastric carcinomas. Cancer Res 1991, 51:2185-2192
28. Ozawa M, Engel J, Kemler R: Single amino acid substitution in one calcium binding site of uvomorulin abolish the adhesive function. Cell 1990, 63:1033-1038
29. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T, Hirohashi S: E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci 1994, 91:1858-1862
30. Knudson AG: Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985, 45:1437-1443
31. Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Halling K, MacLeod P, Powell SM, Jackson CE, Ponder BAJ, Caldas C: Identification of germ-line Ecadherin mutations in gastric cancer families of European origin. Cancer Res 1998, 58:4086-4089
32. Ringwald M, Baribault H, Schmidt C, Kemler R: The structure of the gene coding for the mouse cell adhesion molecule uvomorulin. Nucleic Acids Res 1991, 19:6533-6539
33. Becker KF, Atkinson MJ, Reich U, Huang HH, Nekarda H, Siewert JR, Höfler H: Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum Molec genet 1993, 2:803-804
34. Cowley GP, Smith ME: Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int J Cancer 1995, 60:325-329
35. Smith ME, Pignatelli M: The molecular histology of neoplasia: the role of the cadherin/catenin complex. Histopathol 1997, 31:107-111